E-019 tcar

ConclusionsOur analysis of a single-center cohort demonstrates that TCAR is a safe and effective treatment for symptomatic carotid stenosis, with a low perioperative stroke risk. The present study’s findings concur with the combined adverse outcome rate of 3.5% reported in the ROADSTER trial.Disclosures A. Bajaj: None. S. Monje: None. C. Ayala: None. J. Poggi: None. E. Shaaya: None. J. Feler: None. K. Moldovan: None. C. Doberstein: None. R. McTaggart: None. R. Torabi: None.

Source: Journal of NeuroInterventional Surgery - July 23, 2022 Category: Neurosurgery Authors: Bajaj, A., Monje, S., Ayala, C., Poggi, J., Shaaya, E., Feler, J., Moldovan, K., Doberstein, C., McTaggart, R., Torabi, R. Tags: SNIS 19th annual meeting electronic poster abstracts Source Type: research